Håkansson, A <br/><br/>
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes.  [electronic resource] 

 -  British journal of cancer  Dec 2001 
 - 1871-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1054/bjoc.2001.2169  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Biopsy, Needle<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Cost-Benefit Analysis<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Immunotherapy--economics<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Life Tables<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Predictive Value of Tests<br/>Recombinant Proteins<br/>Survival Analysis<br/>Treatment Outcome